Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
The Long Run with Luke Timmerman
00:00
Preclinical progress and development timeline
Emily shares in vivo efficacy in mouse models, plans to nominate a development candidate within a year.
Play episode from 01:00:41
Transcript
